Gene-editing technique CRISPR identifies dangerous breast cancer
4.7 (696) · $ 11.99 · In stock
Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
Frontiers CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
Translatable gene therapy for lung cancer using Crispr CAS9—an exploratory review
CRISPR Edited Immune Cells Show Positive Results in Cancer Patients
COVID-19 variants – News, Research and Analysis – The Conversation – page 7
Breast cancer – News, Research and Analysis – The Conversation – page 3
Home – Articles, Analysis, Opinion – The Conversation – page 502
CRISPR/Cas genome editing in triple negative breast cancer: Current situation and future directions - ScienceDirect
WHAT IS CRISPR-CAS9?
New tool helps find genetic culprits in cancer's spread
CRISPR/Cas9 templated gene editing analysis in mouse fibroblasts. (A)
Greg Findlay's Instagram, Twitter & Facebook on IDCrawl
Home – Articles, Analysis, Opinion – The Conversation – page 488
Home – Articles, Analysis, Opinion – The Conversation – page 492
Genome editing and cancer: How far has research moved forward on CRISPR/Cas9? - ScienceDirect
